Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06204913 · ClinicalTrials.gov registry record · NA

Menu Label Noticeability

A NA study, sponsored by University of California, Davis.

Completed
Registry status
NA
Development phase
4,581
Enrollment target

NCT06204913: Completed NA study, sponsored by University of California, Davis.

NCT06204913 is a NA study that has completed, run by University of California, Davis. The registered enrollment target is 4,581 participants, above the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (226% higher). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06204913, a NA study, has completed, sponsored by University of California, Davis.

COMPLETED
Registry status
NA
Development phase
4,581 participants
Enrollment target

Study Summary

To assess the relative noticeability of the following added-sugar menu label elements using a factorial experiment: label type (icon-only vs. icon-plus-text label vs. boxed icon), color (black vs. red), size (100% vs. 150% of the height of the menu item text), and placement (left vs. right side of item).

Primary Outcome

Noticing a nutrition label - Measured with "Think back to the beginning of this survey when you imagined you were ordering dinner from restaurant menus. Did you notice any nutrition labels (other than the calories) next to any of the menu items?" Response options are "Yes", "No", and "Don't know". Recalling the label's meaning - \[If answered "Yes"\] Measured with "What did the nutrition label tell you about?" Response options are (displayed in survey in a random order) "Sodium", "Added sugars"

Interventions

  • OTHER Menu label

Trial Details

FieldValue
Enrollment Target 4,581 participants
Start Date 2024-02-15
Est. Completion 2024-03-15
Phase NA
University of California, Davis

657 total trials

What the finished NCT06204913 record still lists

NCT06204913 is an interventional study that assigns participants to a tested intervention. Its 4,581 participants enrollment target places it among the larger protocols in the corpus, above the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (226% higher).

The record links to 0 conditions, and to 1 intervention - of which Menu label is the first listed.

NCT06204913 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT06204913 about?

NCT06204913 is a clinical study titled "Menu Label Noticeability". To assess the relative noticeability of the following added-sugar menu label elements using a factorial experiment: label type (icon-only vs. icon-plus-text label vs. boxed icon), color (black vs. red), size (100% vs. 150% of the height of the menu item text), and placement (left vs. right side of i...

What is the current status of trial NCT06204913?

This trial is currently completed. It is a NA study. The enrollment target is 4,581 participants. The study started on 2024-02-15. Estimated completion is 2024-03-15.

What interventions are being tested in trial NCT06204913?

The interventions under investigation include: Menu label (OTHER).

Who is sponsoring clinical trial NCT06204913?

This trial is sponsored by University of California, Davis, which has 657 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT06204913's enrollment target sits among peer trials

4,581 29th of 2000 higher than 1,972 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT05768217 · 4,600 participants · NA

    Community Resiliency Collective Efficacy Intervention

  • NCT06535139 · 4,630 participants · NA

    ReMARK: Addressing Disparities in Rural HPV-related Cancer Prevention

  • NCT06702878 · 4,514 participants · Phase 3

    Light-Activated Antimicrobial Therapy to Prevent Surgical Site Infections

  • NCT06533111 · 4,500 participants · NA

    Improving Surgical Patient Outcomes Through Implementation of a SemiStructured Intraoperative Anesthesia Handoff Tool

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT06204913, the US trial registry maintained by the National Library of Medicine. NCT06204913 (large enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.